Cutler Group LLC / CA - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$133,000
+1230.0%
5,000
+900.0%
0.01%
+500.0%
Q3 2020$10,000
-9.1%
5000.0%0.00%0.0%
Q2 2020$11,000
+37.5%
5000.0%0.00%
Q1 2020$8,000
-27.3%
5000.0%0.00%
-100.0%
Q4 2019$11,000
-15.4%
5000.0%0.00%0.0%
Q3 2019$13,000
-18.8%
5000.0%0.00%0.0%
Q2 2019$16,000
-5.9%
5000.0%0.00%
-50.0%
Q1 2019$17,000
-80.9%
500
-81.5%
0.00%
-75.0%
Q4 2018$89,000
+4350.0%
2,700
-18.2%
0.01%
Q1 2018$2,000
-77.8%
3,300
-0.4%
0.00%
Q4 2017$9,000
-96.6%
3,312
-73.4%
0.00%
-100.0%
Q3 2017$268,000
+14.0%
12,437
+45.0%
0.01%
+11.1%
Q2 2017$235,000
+197.5%
8,577
-15.1%
0.01%
+200.0%
Q1 2017$79,00010,100
+818.2%
0.00%
Q4 2016$0
-100.0%
1,100
-56.0%
0.00%
Q3 2016$8,000
-55.6%
2,500
-14.0%
0.00%
-100.0%
Q2 2016$18,000
-83.5%
2,906
-80.6%
0.00%
-85.7%
Q1 2016$109,000
-60.9%
15,006
-36.6%
0.01%
-53.3%
Q4 2015$279,00023,6840.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders